Hemab Therapeutics Holdings, Inc. Common Stock (COAG) News

Latest headlines that mention COAG, newest first · each headline opens the original publisher

COAG quote

Last price: $38.13
Day change: -1.65%
Next earnings: —

Quote & chart Expected move Insider trading IV rank history

COAG headlines

last 30 days

Motley Fool 19h ago

Hemab (COAG) Q3 2026 Earnings Call Transcript

Cash runway reaches 2029 as SOLARA Phase III enrollment begins

Earnings T3COAG

Seeking Alpha 20h ago

Hemab expects cash to fund operations into 2029 while advancing ~75-patient SOLARA Phase III

General T2COAG

Seeking Alpha News 20h ago

Hemab Therapeutics Holdings, Inc. (COAG) Q3 2026 Earnings Call Transcript

Earnings T2COAG

Seeking Alpha 1d ago

Hemab Therapeutics Holdings GAAP EPS of -$0.58 misses by $0.06

Earnings T2COAG

Investing.com 2d ago

Hemab initiates phase 3 trial for rare bleeding disorder drug

General T3COAG

Investing.com 27d ago

JPMorgan initiates Hemab Therapeutics stock with overweight rating

General T3COAG JPM

Also mentioned with COAG

30d

JPM1

Headlines that tag both tickers

COAG news alerts

Get an alert by email or push when a new headline mentions COAG.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.